NPPG Administrator, Suite 213, Boundary House, London W7 2QE
Labelling of Dispensed Oral Medicines for Children position statement
Dear colleagues,
I am very pleased to announce the publication of our Labelling Position Statement. This document outlines our stance on accurate, easy to understand and patient-focused labelling practices, which are essential to support safe administration of medicines. It has been published after careful assessment of the available literature and reflects our commitment to clarity, consistency and safety of information provision for patients and families. We hope this statement serves as a valuable reference point for colleagues across all healthcare settings.
Nanna Christiansen
Neonatal and Paediatric Pharmacy Group Chair
Keywords: Children,Labelling, Medicines, Oral Medicines, Liquid medicines, Dosing instructions
Keywords: Adrenaline Amiodarone Atracurium Clonidine Dinoprostone Dobutamine Dopamine Fentanyl Furosemide Heparin Insulin Labetalol Midazolam Milrinine Morphine Noradrenaline Rocuronium Vasopressin Vecuronium Infusions PICU NICU